Received: 9 April 2018
Accepted: 5 June 2018
First Online: 18 June 2018
Ethics approval and consent to participate
: This study was ethically approved by Dr. Yassin Abdel Ghaffar Charity Center for Liver Disease and Research Institutional Review Board No: E-20278-QB.
: The authors declare that they received financial support from Abbvie Pharmaceuticals.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.